{"id":"skin-allograft","safety":{"commonSideEffects":[{"rate":null,"effect":"Graft rejection"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Graft failure/non-take"},{"rate":null,"effect":"Scarring"}]},"_chembl":{"chemblId":"CHEMBL2109200","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Skin allografts are cadaveric or living donor skin grafts that restore the barrier function, reduce infection risk, and promote healing of severe burns, chronic wounds, or traumatic injuries. The graft integrates with the recipient's tissue and can provide both structural support and biological signaling to facilitate wound healing and tissue regeneration.","oneSentence":"A skin allograft is a transplanted human skin tissue from a donor that provides temporary or permanent coverage and biological functions to damaged or missing skin.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:08:21.373Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe burns"},{"name":"Chronic wounds"},{"name":"Traumatic skin injuries"},{"name":"Surgical wound coverage"}]},"trialDetails":[{"nctId":"NCT07193134","phase":"PHASE1, PHASE2","title":"GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment","status":"RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2026-01-07","conditions":"RDEB, Recessive Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa Dystrophica, Recessive","enrollment":9},{"nctId":"NCT06750809","phase":"NA","title":"Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds","status":"ACTIVE_NOT_RECRUITING","sponsor":"Avita Medical","startDate":"2025-02-21","conditions":"Surgical Wound, Trauma Wound, Autografts","enrollment":40},{"nctId":"NCT07290673","phase":"NA","title":"Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers","status":"NOT_YET_RECRUITING","sponsor":"Samaritan Biologics","startDate":"2026-04-01","conditions":"Diabetic Foot Ulcer (DFU)","enrollment":124},{"nctId":"NCT06449638","phase":"NA","title":"Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs","status":"RECRUITING","sponsor":"StimLabs","startDate":"2024-07-16","conditions":"Diabetic Foot Ulcer (DFU), Ulcer Foot, Diabetic Foot","enrollment":272},{"nctId":"NCT06778447","phase":"NA","title":"Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease","status":"RECRUITING","sponsor":"VIVEX Biologics, Inc.","startDate":"2025-02-17","conditions":"Degenerative Disc Disease, Disc Degeneration, Lumbar Discogenic Pain","enrollment":496},{"nctId":"NCT04090424","phase":"NA","title":"Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns","status":"ACTIVE_NOT_RECRUITING","sponsor":"PolyNovo Biomaterials Pty Ltd.","startDate":"2021-09-21","conditions":"Burns","enrollment":150},{"nctId":"NCT05747469","phase":"EARLY_PHASE1","title":"Use of Allograft Adipose Matrix for Small Joint Arthritis of the Hand","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2023-08-28","conditions":"Osteoarthritis Hand","enrollment":34},{"nctId":"NCT07223515","phase":"","title":"HEAL-4: Real-World Effectiveness of 4 Amniotic Allografts Adjunctive to Standard Care in DFU, VLU, and PU","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dynamic Medical Services dba Acesso Biologics","startDate":"2025-10-24","conditions":"Diabetic Foot Ulcer (DFU), Venous Leg Ulcers (VLUs), Pressure Ulcers, Bedsores, Decubitus Ulcer","enrollment":2000},{"nctId":"NCT06926699","phase":"NA","title":"MPFL Reconstruction Versus Rehabilitation","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2026-01-01","conditions":"Patellar (or Kneecap) Instability and Mal-alignment, Patellar Dislocation","enrollment":30},{"nctId":"NCT04537026","phase":"PHASE1, PHASE2","title":"Sterile Amniotic Fluid Filtrate Epidural Injection.","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-06-16","conditions":"Lumbar Spinal Stenosis","enrollment":61},{"nctId":"NCT07173621","phase":"NA","title":"Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach","status":"ENROLLING_BY_INVITATION","sponsor":"Sarasota Memorial Health Care System","startDate":"2025-10-01","conditions":"Thyroid; Wound, Parathyroid Diseases, Surgical Incision","enrollment":334},{"nctId":"NCT02055521","phase":"NA","title":"Search Tolerance Signature in Vascularised Composite Allograft","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2013-10","conditions":"Hand and Face Allotransplantation","enrollment":18},{"nctId":"NCT04243889","phase":"NA","title":"Fetoscopic NEOX Cord 1K® Spina Bifida Repair","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-08-28","conditions":"Spina Bifida, Myelomeningocele, Myeloschisis","enrollment":50},{"nctId":"NCT04848493","phase":"","title":"National Project on Vaccines, COVID-19 and Frail Patients","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2021-04-19","conditions":"COVID-19, Solid Tumor, Hematologic Diseases","enrollment":747},{"nctId":"NCT06437028","phase":"NA","title":"Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.","status":"RECRUITING","sponsor":"Samaritan Biologics","startDate":"2025-05-09","conditions":"Diabetic Foot Ulcer","enrollment":170},{"nctId":"NCT06681428","phase":"NA","title":"Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers","status":"RECRUITING","sponsor":"Tides Medical","startDate":"2024-11-14","conditions":"Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers","enrollment":240},{"nctId":"NCT06073301","phase":"PHASE4","title":"AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kerecis Ltd.","startDate":"2023-08-01","conditions":"Necrotizing Fasciitis","enrollment":30},{"nctId":"NCT01614665","phase":"PHASE2","title":"A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time","status":"COMPLETED","sponsor":"Astellas Pharma Europe Ltd.","startDate":"2012-04-03","conditions":"Heart Transplantation, Kidney Transplantation, Liver Transplantation","enrollment":44},{"nctId":"NCT05251480","phase":"NA","title":"Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People","status":"NOT_YET_RECRUITING","sponsor":"DeCell Technologies Inc.","startDate":"2024-12-30","conditions":"Diabetes Mellitus, Ulcer Foot, Ulcer Healing","enrollment":120},{"nctId":"NCT03695939","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds","status":"COMPLETED","sponsor":"XenoTherapeutics, Inc.","startDate":"2019-03-15","conditions":"Deep Full-thickness Burn Injury (Disorder)","enrollment":25},{"nctId":"NCT05344521","phase":"PHASE1","title":"A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-02","conditions":"Burns","enrollment":29},{"nctId":"NCT02047084","phase":"","title":"Comparison of Human Allograft to Apligraf for Venous Leg Ulcers","status":"ENROLLING_BY_INVITATION","sponsor":"Solsys Medical LLC","startDate":"2013-06","conditions":"Venous Leg Ulcers","enrollment":50},{"nctId":"NCT06066931","phase":"NA","title":"Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE","status":"NOT_YET_RECRUITING","sponsor":"Kuban State Medical University","startDate":"2023-10-01","conditions":"Rectum Cancer","enrollment":150},{"nctId":"NCT04021316","phase":"NA","title":"Decellularised Dermis Allograft for the Treatment of Chronic Venous Leg Ulceration","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2019-10-01","conditions":"Venous Ulcer, Allograft","enrollment":71},{"nctId":"NCT05477225","phase":"PHASE4","title":"A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions","status":"UNKNOWN","sponsor":"Joseph M. Still Research Foundation, Inc.","startDate":"2022-10-01","conditions":"Hidradenitis Suppurativa","enrollment":10},{"nctId":"NCT00896012","phase":"PHASE4","title":"Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2008-01","conditions":"Kidney Transplantation","enrollment":58},{"nctId":"NCT05017961","phase":"NA","title":"Comparing Efficacy of Bone Marrow Aspirate Concentrate (BMAC) Combined With Allograft in Treatment of Calcaneus Fractures","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2019-07-10","conditions":"Fractures, Bone","enrollment":""},{"nctId":"NCT02891759","phase":"PHASE2","title":"Compare Outcomes Between Two Acellular Dermal Matrices","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-01-31","conditions":"Breast Cancer","enrollment":320},{"nctId":"NCT02314468","phase":"NA","title":"Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation","status":"WITHDRAWN","sponsor":"University Hospital, Ghent","startDate":"2013-10","conditions":"Necrotizing Soft Tissue Infection","enrollment":""},{"nctId":"NCT01771679","phase":"PHASE1, PHASE2","title":"Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging","status":"UNKNOWN","sponsor":"Stemedica Cell Technologies, Inc.","startDate":"2015-07-01","conditions":"Chronic Effect of Ultraviolet Radiation on Photoaged Skin, Dermatologic Disorders","enrollment":29},{"nctId":"NCT03312803","phase":"NA","title":"Mini-autogenous Skin Grafts With Skin Homografts Versus Autogenous Skin Graft for Covering Post Burn Wounds in Children","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-09-01","conditions":"Burns","enrollment":20},{"nctId":"NCT00849888","phase":"PHASE1","title":"Serum-Free Thymus Transplantation in DiGeorge Anomaly","status":"TERMINATED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2008-04","conditions":"DiGeorge Anomaly","enrollment":2},{"nctId":"NCT00576836","phase":"PHASE2","title":"Thymus Transplantation Dose in DiGeorge #932","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2004-09-02","conditions":"DiGeorge Anomaly, DiGeorge Syndrome, Complete DiGeorge Anomaly","enrollment":7},{"nctId":"NCT00576407","phase":"PHASE2","title":"Thymus Transplantation in DiGeorge Syndrome #668","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"1991-10","conditions":"DiGeorge Syndrome, Complete Typical DiGeorge Anomaly","enrollment":26},{"nctId":"NCT00579527","phase":"PHASE1, PHASE2","title":"Phase I/II Thymus Transplantation With Immunosuppression #950","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2005-12-19","conditions":"DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly","enrollment":14},{"nctId":"NCT04040426","phase":"NA","title":"Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Professional Education and Research Institute","startDate":"2019-08-06","conditions":"Diabetic Foot, Ulcer Foot","enrollment":100},{"nctId":"NCT02870816","phase":"NA","title":"Prospective, Comparitive, Randomized Study of Allograft Versus Skin Substitute in Non-healing Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Professional Education and Research Institute","startDate":"2016-08-31","conditions":"Diabetic Foot Ulcer","enrollment":60},{"nctId":"NCT05024656","phase":"NA","title":"AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers","status":"WITHDRAWN","sponsor":"Integra LifeSciences Corporation","startDate":"2021-09","conditions":"Diabetic Foot Ulcer","enrollment":""},{"nctId":"NCT01140087","phase":"NA","title":"Face Transplantation","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-09","conditions":"Transplantation: Facial Transplantation","enrollment":1},{"nctId":"NCT04162639","phase":"PHASE4","title":"The Relationship Between Cadaveric Allograft Skin and HLA-Sensitivity in Burn Patients","status":"WITHDRAWN","sponsor":"Virginia Commonwealth University","startDate":"2021-02","conditions":"Burns","enrollment":""},{"nctId":"NCT04673435","phase":"NA","title":"Permeaderm Versus Homograft for Full-thickness Burns","status":"WITHDRAWN","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2018-01-31","conditions":"Full Thickness Burn","enrollment":""},{"nctId":"NCT03547635","phase":"NA","title":"AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Integra LifeSciences Corporation","startDate":"2018-05-03","conditions":"Diabetic Foot Ulcer","enrollment":116},{"nctId":"NCT00887068","phase":"PHASE3","title":"Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-04-21","conditions":"Leukemia, AML, MDS","enrollment":187},{"nctId":"NCT00676013","phase":"NA","title":"Comparison of Skin Substitutes Used in Burn Care","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"1997-12","conditions":"Burns","enrollment":158},{"nctId":"NCT00185692","phase":"PHASE2","title":"Allogeneic Transplantation From Related Haploidentical Donors","status":"COMPLETED","sponsor":"Stanford University","startDate":"2000-08","conditions":"Blood Cancer, Leukemia, Graft Versus Host Disease","enrollment":16},{"nctId":"NCT00618839","phase":"PHASE1, PHASE2","title":"StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects","status":"COMPLETED","sponsor":"Stratatech, a Mallinckrodt Company","startDate":"2006-07","conditions":"Third Degree Burn, Burns, Wound Infection","enrollment":15},{"nctId":"NCT03044132","phase":"NA","title":"DermACELL AWM® in Chronic Wagner Grade 3/4 Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"LifeNet Health","startDate":"2017-01-15","conditions":"Diabetic Foot Ulcer, Lower Extremity Wound","enrollment":61},{"nctId":"NCT03999281","phase":"","title":"Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU","status":"COMPLETED","sponsor":"Solsys Medical LLC","startDate":"2003-03-20","conditions":"Determine Effectiveness of Theraskin in the Treatment of DFU and VLU","enrollment":188},{"nctId":"NCT01676272","phase":"","title":"Multi Center Site , Controlled Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograft","status":"COMPLETED","sponsor":"Solsys Medical LLC","startDate":"2012-07","conditions":"Diabetic Foot Ulcer","enrollment":23},{"nctId":"NCT03935386","phase":"NA","title":"Standard Compression Therapy With/Without Application of Skin Allograft (Theraskin) for Venous Leg Ulcer Treatment","status":"UNKNOWN","sponsor":"Solsys Medical LLC","startDate":"2015-11","conditions":"Chronic Venous Hypertension With Ulcer","enrollment":100},{"nctId":"NCT03183258","phase":"PHASE1, PHASE2","title":"Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2016-05-19","conditions":"Pancreas Transplant Rejection","enrollment":20},{"nctId":"NCT00654615","phase":"NA","title":"Fixation of Unstable Distal Radius Fractures","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2008-05","conditions":"Distal Radius Fractures","enrollment":60},{"nctId":"NCT03521258","phase":"NA","title":"Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane","status":"UNKNOWN","sponsor":"Louisiana State University Health Sciences Center in New Orleans","startDate":"2016-02","conditions":"Wounds, Trauma, Injury","enrollment":53},{"nctId":"NCT00855569","phase":"","title":"Hemostatic Textile to Control Bleeding at Donor Graft Sites","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2008-06","conditions":"Wounds","enrollment":20},{"nctId":"NCT02209051","phase":"NA","title":"Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Integra LifeSciences Corporation","startDate":"2014-07","conditions":"Diabetic Foot Ulcers","enrollment":29},{"nctId":"NCT00245037","phase":"PHASE1, PHASE2","title":"Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer","status":"COMPLETED","sponsor":"OHSU Knight Cancer Institute","startDate":"2005-06","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":147},{"nctId":"NCT02936128","phase":"PHASE4","title":"TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers","status":"TERMINATED","sponsor":"Osiris Therapeutics","startDate":"2016-07","conditions":"Chronic Venous Leg Ulcers","enrollment":7},{"nctId":"NCT02936115","phase":"PHASE4","title":"TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers","status":"TERMINATED","sponsor":"Osiris Therapeutics","startDate":"2016-07","conditions":"Diabetic Foot Ulcers","enrollment":14},{"nctId":"NCT01655407","phase":"PHASE2","title":"Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds","status":"UNKNOWN","sponsor":"Amarantus BioScience Holdings, Inc.","startDate":"2016-09","conditions":"Thermal Injury, Deep Partial-Thickness Burn, Full-Thickness Burn","enrollment":10},{"nctId":"NCT01616043","phase":"PHASE3","title":"Glyaderm Clinical Evaluation Multicenter Study","status":"TERMINATED","sponsor":"Euro Tissue Bank","startDate":"2011-02","conditions":"Full-thickness Skin Loss Due to Burn, Unspecified Site","enrollment":40},{"nctId":"NCT02445118","phase":"","title":"Allograft Adipose Matrix (AAM) in Subcutaneous Dorsal Wrist","status":"COMPLETED","sponsor":"Musculoskeletal Transplant Foundation","startDate":"2015-05","conditions":"Aesthetic Rejuvenation","enrollment":15},{"nctId":"NCT00089180","phase":"PHASE2","title":"T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-03","conditions":"Actinic Keratosis, Basal Cell Carcinoma of the Skin, Recurrent Skin Cancer","enrollment":100},{"nctId":"NCT01330407","phase":"PHASE3","title":"Comparative Assessment of Adjuvant Effect of Cultured Epidermal Autografts Versus Skin Allografts on Wound Healing of Burns Treated With Widely Expanded Skin Autograft Using Meek Micrografting Technique MEEKADEAU","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2011-04","conditions":"Burn Wounds","enrollment":10},{"nctId":"NCT01033604","phase":"NA","title":"Glyaderm + Split Thickness Skin Graft Versus Split Thickness Skin Graft Alone in Full Thickness Skin Defects","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2007-09","conditions":"Full Thickness Skin Defects","enrollment":31},{"nctId":"NCT00795132","phase":"PHASE2","title":"Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"University of Utah","startDate":"2004-04","conditions":"Acute Leukaemia, Chronic Disease, Leukemia","enrollment":47},{"nctId":"NCT01562119","phase":"","title":"Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2011-01","conditions":"Burn, Traumatic Implants","enrollment":30},{"nctId":"NCT00129961","phase":"PHASE4","title":"Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-08","conditions":"Skin Neoplasms, Kidney Transplantation","enrollment":86}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Skin allograft","genericName":"Skin allograft","companyName":"Virginia Commonwealth University","companyId":"virginia-commonwealth-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"A skin allograft is a transplanted human skin tissue from a donor that provides temporary or permanent coverage and biological functions to damaged or missing skin. Used for Severe burns, Chronic wounds, Traumatic skin injuries.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}